Yanlin Niu
Yanlin Niu
1Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
Writing – original draft, Writing – review & editing
1,†,
Shengchao Wang
Shengchao Wang
1Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
2Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China
Data curation, Writing – review & editing
1,2,†,
Xinzhou Deng
Xinzhou Deng
1Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
2Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China
Writing – review & editing
1,2,
Ming Luo
Ming Luo
1Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
2Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China
Writing – review & editing
1,2,*,
Jingjing Chai
Jingjing Chai
1Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
2Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China
Writing – review & editing
1,2,*,
Zhiguo Luo
Zhiguo Luo
1Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
2Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China
Writing – review & editing
1,2,*
1Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
2Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China
*Correspondence: Ming Luo, heavry@126.com; Jingjing Chai, chaijingjing@hbmu.edu.cn; Zhiguo Luo, luozhiguo@hbmu.edu.cn
†These authors have contributed equally to this work
Roles
Yanlin Niu: Writing – original draft, Writing – review & editing
Shengchao Wang: Data curation, Writing – review & editing
Xinzhou Deng: Writing – review & editing
Ming Luo: Writing – review & editing
Jingjing Chai: Writing – review & editing
Zhiguo Luo: Writing – review & editing
Received 2025 Nov 22; Accepted 2025 Nov 24; Collection date 2025.
Keywords: renal squamous cell carcinoma, pulmonary metastases, immunotherapy, radiotherapy, chemotherapy
Copyright © 2025 Niu, Wang, Deng, Luo, Chai and Luo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.